LabCompass

Diana Zepeda‐Orozco

Medicine · The Ohio State University

Mid career · publishing since 2008Rising activity

Publications

62

Citations

1,334

Est. group size

~8

Recurring co-author estimate

Active years

18

Publishing since 2008

Research summary
AI-generated

Diana Zepeda-Orozco's research focuses on kidney injury and disease, particularly the toxic effects that cancer treatments like cisplatin chemotherapy have on the kidneys. Her work spans laboratory studies of the underlying biology (such as oxidative stress and mitochondrial damage in kidney cells), biomarker development to detect kidney damage early, and clinical trials testing protective drugs like avasopasem manganese in cancer patients. She also studies chronic kidney disease more broadly, including in pediatric patients.

Cisplatin-induced kidney injury and chronic kidney diseaseOxidative stress and mitochondrial dysfunction in the kidneyNephroprotective drug development and clinical trialsKidney injury biomarkersPediatric kidney and renal function assessment

Publication output was modest and fairly steady from 2017-2021 (1-4 papers/year) before increasing sharply from 2022 onward, peaking at 19 publications in 2023 and remaining elevated through 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.0/year recently
2017: 3 publications172018: 1 publication182019: 3 publications192020: 4 publications202021: 2 publications212022: 5 publications222023: 19 publications19232024: 8 publications242025: 8 publications2526
Recent publications
Publishes in
  • Journal of the American Society of Nephrology×12
  • Redox Biology×3
  • Antioxidants×3
  • bioRxiv (Cold Spring Harbor Laboratory)×3
  • Kidney International×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile